OBJECTIVE: Osteoporosis, common in European and South American adults with
celiac disease, has not been reported in those patients with celiac disease
residing in North America. We therefore evaluated bone density in a group
of patients from the United States.
METHODS: Patients (105 women and 23 men) with celiac disease, who had compl
eted a questionnaire and had bone mineral density (BMD) measured by dual en
ergy x-ray absorptiometry, were evaluated. The patients were an aver age ag
e of 56 yr old (range 21-83 yr) and had been on a gluten-free diet from 0 m
onths to 46 yr (mean 7.5 yr).
RESULTS: Osteoporosis (T score <-2.5) was present in 34% of the patients at
the lumbar spine, 27% at the femoral neck, and 36% at the radius. Low bone
mass (T score between -1.0 and -2.5) was present in 38% at the lumbar spin
e, 44% at the femoral neck, and 32% at the radius. When compared to age-mat
ched controls, men were more severely affected than women. BMD did not diff
er between those on a gluten-free diet and those who had not begun therapy.
BMD was remeasured 16 +/- 2 months after beginning a gluten-free diet in 5
patients; it increased by 7.5% at the femoral neck (p < 0.02). In 16 patie
nts who had followed a gluten-free diet for an average of 12 yr, BMD remain
ed stable over an additional 2 yr of observation.
CONCLUSIONS: Osteoporosis and low bone mass often affect North American adu
lts with celiac disease, whether or not they are on dietary therapy. Routin
e screening for osteoporosis is indicated in patients with celiac disease.
(Am J Gastroenterol 2001;96:112-119. (C) 2001 by Am. Coll. of Gastroenterol
ogy).